1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Mucopolysaccharidosis (MPS) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Stem Cell Therapies 1.2.3 Enzyme Replacement Therapies 1.3 Market by Application 1.3.1 Global Mucopolysaccharidosis (MPS) Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Homecare 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Mucopolysaccharidosis (MPS) Treatment Market Perspective (2016-2027) 2.2 Mucopolysaccharidosis (MPS) Treatment Growth Trends by Regions 2.2.1 Mucopolysaccharidosis (MPS) Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Mucopolysaccharidosis (MPS) Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Mucopolysaccharidosis (MPS) Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Mucopolysaccharidosis (MPS) Treatment Industry Dynamic 2.3.1 Mucopolysaccharidosis (MPS) Treatment Market Trends 2.3.2 Mucopolysaccharidosis (MPS) Treatment Market Drivers 2.3.3 Mucopolysaccharidosis (MPS) Treatment Market Challenges 2.3.4 Mucopolysaccharidosis (MPS) Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Mucopolysaccharidosis (MPS) Treatment Players by Revenue 3.1.1 Global Top Mucopolysaccharidosis (MPS) Treatment Players by Revenue (2016-2021) 3.1.2 Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Mucopolysaccharidosis (MPS) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Mucopolysaccharidosis (MPS) Treatment Revenue 3.4 Global Mucopolysaccharidosis (MPS) Treatment Market Concentration Ratio 3.4.1 Global Mucopolysaccharidosis (MPS) Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Mucopolysaccharidosis (MPS) Treatment Revenue in 2020 3.5 Mucopolysaccharidosis (MPS) Treatment Key Players Head office and Area Served 3.6 Key Players Mucopolysaccharidosis (MPS) Treatment Product Solution and Service 3.7 Date of Enter into Mucopolysaccharidosis (MPS) Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Mucopolysaccharidosis (MPS) Treatment Breakdown Data by Type 4.1 Global Mucopolysaccharidosis (MPS) Treatment Historic Market Size by Type (2016-2021) 4.2 Global Mucopolysaccharidosis (MPS) Treatment Forecasted Market Size by Type (2022-2027) 5 Mucopolysaccharidosis (MPS) Treatment Breakdown Data by Application 5.1 Global Mucopolysaccharidosis (MPS) Treatment Historic Market Size by Application (2016-2021) 5.2 Global Mucopolysaccharidosis (MPS) Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Mucopolysaccharidosis (MPS) Treatment Market Size (2016-2027) 6.2 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Type 6.2.1 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2021) 6.2.2 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2022-2027) 6.2.3 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2027) 6.3 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Application 6.3.1 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2021) 6.3.2 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2022-2027) 6.3.3 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2027) 6.4 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Country 6.4.1 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2016-2021) 6.4.2 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Mucopolysaccharidosis (MPS) Treatment Market Size (2016-2027) 7.2 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Type 7.2.1 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2021) 7.2.2 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2022-2027) 7.2.3 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2027) 7.3 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Application 7.3.1 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2021) 7.3.2 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2022-2027) 7.3.3 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2027) 7.4 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Country 7.4.1 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2016-2021) 7.4.2 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size (2016-2027) 8.2 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Type 8.2.1 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Application 8.3.1 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Region 8.4.1 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size (2016-2027) 9.2 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Type 9.2.1 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2027) 9.3 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Application 9.3.1 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2021) 9.3.2 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2022-2027) 9.3.3 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2027) 9.4 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Country 9.4.1 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size (2016-2027) 10.2 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Type 10.2.1 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Application 10.3.1 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Country 10.4.1 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Sanofi 11.1.1 Sanofi Company Details 11.1.2 Sanofi Business Overview 11.1.3 Sanofi Mucopolysaccharidosis (MPS) Treatment Introduction 11.1.4 Sanofi Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) 11.1.5 Sanofi Recent Development 11.2 Shire (Takeda) 11.2.1 Shire (Takeda) Company Details 11.2.2 Shire (Takeda) Business Overview 11.2.3 Shire (Takeda) Mucopolysaccharidosis (MPS) Treatment Introduction 11.2.4 Shire (Takeda) Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) 11.2.5 Shire (Takeda) Recent Development 11.3 BioMarin Pharmaceutical 11.3.1 BioMarin Pharmaceutical Company Details 11.3.2 BioMarin Pharmaceutical Business Overview 11.3.3 BioMarin Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Introduction 11.3.4 BioMarin Pharmaceutical Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) 11.3.5 BioMarin Pharmaceutical Recent Development 11.4 Esteve 11.4.1 Esteve Company Details 11.4.2 Esteve Business Overview 11.4.3 Esteve Mucopolysaccharidosis (MPS) Treatment Introduction 11.4.4 Esteve Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) 11.4.5 Esteve Recent Development 11.5 REGENXBIO Inc 11.5.1 REGENXBIO Inc Company Details 11.5.2 REGENXBIO Inc Business Overview 11.5.3 REGENXBIO Inc Mucopolysaccharidosis (MPS) Treatment Introduction 11.5.4 REGENXBIO Inc Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) 11.5.5 REGENXBIO Inc Recent Development 11.6 Sangamo Therapeutics 11.6.1 Sangamo Therapeutics Company Details 11.6.2 Sangamo Therapeutics Business Overview 11.6.3 Sangamo Therapeutics Mucopolysaccharidosis (MPS) Treatment Introduction 11.6.4 Sangamo Therapeutics Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) 11.6.5 Sangamo Therapeutics Recent Development 11.7 Ultragenyx Pharmaceutical 11.7.1 Ultragenyx Pharmaceutical Company Details 11.7.2 Ultragenyx Pharmaceutical Business Overview 11.7.3 Ultragenyx Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Introduction 11.7.4 Ultragenyx Pharmaceutical Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) 11.7.5 Ultragenyx Pharmaceutical Recent Development 11.8 Abeona Therapeutics 11.8.1 Abeona Therapeutics Company Details 11.8.2 Abeona Therapeutics Business Overview 11.8.3 Abeona Therapeutics Mucopolysaccharidosis (MPS) Treatment Introduction 11.8.4 Abeona Therapeutics Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) 11.8.5 Abeona Therapeutics Recent Development 11.9 ArmaGen 11.9.1 ArmaGen Company Details 11.9.2 ArmaGen Business Overview 11.9.3 ArmaGen Mucopolysaccharidosis (MPS) Treatment Introduction 11.9.4 ArmaGen Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) 11.9.5 ArmaGen Recent Development 11.10 Eloxx Pharmaceuticals 11.10.1 Eloxx Pharmaceuticals Company Details 11.10.2 Eloxx Pharmaceuticals Business Overview 11.10.3 Eloxx Pharmaceuticals Mucopolysaccharidosis (MPS) Treatment Introduction 11.10.4 Eloxx Pharmaceuticals Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) 11.10.5 Eloxx Pharmaceuticals Recent Development 11.11 Inventiva 11.11.1 Inventiva Company Details 11.11.2 Inventiva Business Overview 11.11.3 Inventiva Mucopolysaccharidosis (MPS) Treatment Introduction 11.11.4 Inventiva Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) 11.11.5 Inventiva Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Mucopolysaccharidosis (MPS) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Stem Cell Therapies Table 3. Key Players of Enzyme Replacement Therapies Table 4. Global Mucopolysaccharidosis (MPS) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Mucopolysaccharidosis (MPS) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Mucopolysaccharidosis (MPS) Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Mucopolysaccharidosis (MPS) Treatment Market Share by Regions (2016-2021) Table 8. Global Mucopolysaccharidosis (MPS) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Mucopolysaccharidosis (MPS) Treatment Market Share by Regions (2022-2027) Table 10. Mucopolysaccharidosis (MPS) Treatment Market Trends Table 11. Mucopolysaccharidosis (MPS) Treatment Market Drivers Table 12. Mucopolysaccharidosis (MPS) Treatment Market Challenges Table 13. Mucopolysaccharidosis (MPS) Treatment Market Restraints Table 14. Global Mucopolysaccharidosis (MPS) Treatment Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Mucopolysaccharidosis (MPS) Treatment Market Share by Players (2016-2021) Table 16. Global Top Mucopolysaccharidosis (MPS) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mucopolysaccharidosis (MPS) Treatment as of 2020) Table 17. Ranking of Global Top Mucopolysaccharidosis (MPS) Treatment Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Mucopolysaccharidosis (MPS) Treatment Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Mucopolysaccharidosis (MPS) Treatment Product Solution and Service Table 21. Date of Enter into Mucopolysaccharidosis (MPS) Treatment Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2021) (US$ Million) Table 24. Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Type (2016-2021) Table 25. Global Mucopolysaccharidosis (MPS) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Mucopolysaccharidosis (MPS) Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Application (2016-2021) Table 29. Global Mucopolysaccharidosis (MPS) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2021) (US$ Million) Table 32. North America Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2021) (US$ Million) Table 34. North America Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2022-2027) & (US$ Million) Table 61. Sanofi Company Details Table 62. Sanofi Business Overview Table 63. Sanofi Mucopolysaccharidosis (MPS) Treatment Product Table 64. Sanofi Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) & (US$ Million) Table 65. Sanofi Recent Development Table 66. Shire (Takeda) Company Details Table 67. Shire (Takeda) Business Overview Table 68. Shire (Takeda) Mucopolysaccharidosis (MPS) Treatment Product Table 69. Shire (Takeda) Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) & (US$ Million) Table 70. Shire (Takeda) Recent Development Table 71. BioMarin Pharmaceutical Company Details Table 72. BioMarin Pharmaceutical Business Overview Table 73. BioMarin Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Product Table 74. BioMarin Pharmaceutical Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) & (US$ Million) Table 75. BioMarin Pharmaceutical Recent Development Table 76. Esteve Company Details Table 77. Esteve Business Overview Table 78. Esteve Mucopolysaccharidosis (MPS) Treatment Product Table 79. Esteve Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) & (US$ Million) Table 80. Esteve Recent Development Table 81. REGENXBIO Inc Company Details Table 82. REGENXBIO Inc Business Overview Table 83. REGENXBIO Inc Mucopolysaccharidosis (MPS) Treatment Product Table 84. REGENXBIO Inc Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) & (US$ Million) Table 85. REGENXBIO Inc Recent Development Table 86. Sangamo Therapeutics Company Details Table 87. Sangamo Therapeutics Business Overview Table 88. Sangamo Therapeutics Mucopolysaccharidosis (MPS) Treatment Product Table 89. Sangamo Therapeutics Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) & (US$ Million) Table 90. Sangamo Therapeutics Recent Development Table 91. Ultragenyx Pharmaceutical Company Details Table 92. Ultragenyx Pharmaceutical Business Overview Table 93. Ultragenyx Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Product Table 94. Ultragenyx Pharmaceutical Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) & (US$ Million) Table 95. Ultragenyx Pharmaceutical Recent Development Table 96. Abeona Therapeutics Company Details Table 97. Abeona Therapeutics Business Overview Table 98. Abeona Therapeutics Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) & (US$ Million) Table 99. Abeona Therapeutics Recent Development Table 100. ArmaGen Company Details Table 101. ArmaGen Business Overview Table 102. ArmaGen Mucopolysaccharidosis (MPS) Treatment Product Table 103. ArmaGen Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) & (US$ Million) Table 104. ArmaGen Recent Development Table 105. Eloxx Pharmaceuticals Company Details Table 106. Eloxx Pharmaceuticals Business Overview Table 107. Eloxx Pharmaceuticals Mucopolysaccharidosis (MPS) Treatment Product Table 108. Eloxx Pharmaceuticals Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) & (US$ Million) Table 109. Eloxx Pharmaceuticals Recent Development Table 110. Inventiva Company Details Table 111. Inventiva Business Overview Table 112. Inventiva Mucopolysaccharidosis (MPS) Treatment Product Table 113. Inventiva Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) & (US$ Million) Table 114. Inventiva Recent Development Table 115. Research Programs/Design for This Report Table 116. Key Data Information from Secondary Sources Table 117. Key Data Information from Primary Sources List of Figures Figure 1. Global Mucopolysaccharidosis (MPS) Treatment Market Share by Type: 2020 VS 2027 Figure 2. Stem Cell Therapies Features Figure 3. Enzyme Replacement Therapies Features Figure 4. Global Mucopolysaccharidosis (MPS) Treatment Market Share by Application: 2020 VS 2027 Figure 5. Hospitals Case Studies Figure 6. Clinics Case Studies Figure 7. Homecare Case Studies Figure 8. Mucopolysaccharidosis (MPS) Treatment Report Years Considered Figure 9. Global Mucopolysaccharidosis (MPS) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Mucopolysaccharidosis (MPS) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Mucopolysaccharidosis (MPS) Treatment Market Share by Regions: 2020 VS 2027 Figure 12. Global Mucopolysaccharidosis (MPS) Treatment Market Share by Regions (2022-2027) Figure 13. Global Mucopolysaccharidosis (MPS) Treatment Market Share by Players in 2020 Figure 14. Global Top Mucopolysaccharidosis (MPS) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mucopolysaccharidosis (MPS) Treatment as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Mucopolysaccharidosis (MPS) Treatment Revenue in 2020 Figure 16. Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Type (2016-2021) Figure 17. Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Type (2022-2027) Figure 18. North America Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Mucopolysaccharidosis (MPS) Treatment Market Share by Type (2016-2027) Figure 20. North America Mucopolysaccharidosis (MPS) Treatment Market Share by Application (2016-2027) Figure 21. North America Mucopolysaccharidosis (MPS) Treatment Market Share by Country (2016-2027) Figure 22. United States Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Mucopolysaccharidosis (MPS) Treatment Market Share by Type (2016-2027) Figure 26. Europe Mucopolysaccharidosis (MPS) Treatment Market Share by Application (2016-2027) Figure 27. Europe Mucopolysaccharidosis (MPS) Treatment Market Share by Country (2016-2027) Figure 28. Germany Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Share by Type (2016-2027) Figure 36. Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Share by Application (2016-2027) Figure 37. Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Share by Region (2016-2027) Figure 38. China Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Mucopolysaccharidosis (MPS) Treatment Market Share by Type (2016-2027) Figure 46. Latin America Mucopolysaccharidosis (MPS) Treatment Market Share by Application (2016-2027) Figure 47. Latin America Mucopolysaccharidosis (MPS) Treatment Market Share by Country (2016-2027) Figure 48. Mexico Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Share by Type (2016-2027) Figure 52. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Share by Application (2016-2027) Figure 53. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Share by Country (2016-2027) Figure 54. Turkey Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Sanofi Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) Figure 58. Shire (Takeda) Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) Figure 59. BioMarin Pharmaceutical Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) Figure 60. Esteve Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) Figure 61. REGENXBIO Inc Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) Figure 62. Sangamo Therapeutics Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) Figure 63. Ultragenyx Pharmaceutical Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) Figure 64. Abeona Therapeutics Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) Figure 65. ArmaGen Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) Figure 66. Eloxx Pharmaceuticals Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) Figure 67. Inventiva Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) Figure 68. Bottom-up and Top-down Approaches for This Report Figure 69. Data Triangulation Figure 70. Key Executives Interviewed

Sanofi Shire (Takeda) BioMarin Pharmaceutical Esteve REGENXBIO Inc Sangamo Therapeutics Ultragenyx Pharmaceutical Abeona Therapeutics ArmaGen Eloxx Pharmaceuticals Inventiva